In addition, tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and GLP-1 receptors, resulted in even more pronounced weight loss effects, suggesting a potential advantage over traditional GLP-1 RAs
Track glucose levels, weight loss, and semaglutide side effects
[1] [2] This weekly dosing schedule is consistent with other agents in the incretin-based therapy class, such as semaglutide and tirzepatide, and is designed to maintain stable drug levels in the body throughout the treatment period
Lyophilized tirzepatide can be stored at room temperature for extended periods (months in many cases) without significant potency loss
Month one establishes that the medication is tolerated and produces initial weight loss
Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury